Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 30
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
2.
Oncogene ; 31(13): 1673-82, 2012 Mar 29.
Artigo em Inglês | MEDLINE | ID: mdl-21822313

RESUMO

CAPC, also known as LRRC26, is expressed in normal prostate and salivary gland. We developed a mAb to CAPC and used it to characterize the protein and study its function. CAPC protein was detected in normal prostate and salivary gland, in several human breast cancer cell lines and in the prostate cancer cell line LNCaP. Knockdown of CAPC by siRNA in LNCaP cells enhanced anchorage-independent growth in soft agar. Conversely, overexpression of CAPC in MDA-231 breast cancer cells and A431 epidermoid cancer cells inhibited growth in soft agar and tumorigenesis in nude mice, and suppressed the metastasis of MDA-231 cells to the lung. Overexpression of CAPC downregulated NF-κB activity and its target genes, including GM-CSF (CSF2), CXCL1, IL8 and LTB1. It also suppressed genes encoding the serine protease mesotrypsin (PRSS3) and cystatin SN (CST1). CAPC expressing tumors showed a decrease in the number of proliferating cells and a large increase in ECM. The role of CAPC in the suppression of tumor growth and metastasis may be through its alteration of the tumor microenvironment.


Assuntos
Neoplasias da Mama/metabolismo , Proteínas de Neoplasias/fisiologia , Neoplasias da Próstata/metabolismo , Animais , Carcinoma de Células Escamosas/metabolismo , Linhagem Celular Tumoral , Feminino , Técnicas de Silenciamento de Genes , Humanos , Neoplasias Pulmonares/secundário , Masculino , Camundongos , Camundongos Nus , NF-kappa B/genética , Metástase Neoplásica , Proteínas de Neoplasias/genética , Ativação Transcricional
3.
Diabetologia ; 54(11): 2911-22, 2011 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-21842266

RESUMO

AIMS/HYPOTHESIS: ANKRD26 is a newly described gene located at 10p12 in humans, a locus that has been identified with some forms of hereditary obesity. Previous studies have shown that partial inactivation of Ankrd26 in mice causes hyperphagia, obesity and gigantism. Hypothesising that Ankrd26 mutant (MT) mice could develop diabetes, we sought to establish whether the observed phenotype could be (1) solely related to the development of obesity or (2) caused by a direct action of ankyrin repeat domain 26 (ANKRD26) in peripheral tissues. METHODS: To test the hypothesis, we did a full metabolic characterisation of Ankrd26 MT mice that had free access to chow or were placed under two different energy-restricted dietary regimens. RESULTS: Highly obese Ankrd26 MT mice developed an unusual form of diabetes in which white adipose tissue is insulin-sensitive, while other tissues are insulin-resistant. When obese MT mice were placed on a food-restricted diet, their weight and glucose homeostasis returned to normal. In addition, when young MT mice were placed on a pair-feeding diet with normal mice, they maintained normal body weight, but showed better glucose tolerance than normal mice, an increased responsiveness of white adipose tissue to insulin and enhanced phosphorylation of the insulin receptor. CONCLUSIONS/INTERPRETATION: These findings show that the ANKRD26 protein has at least two functions in mice. One is to control the response of white adipose tissue to insulin; the other is to control appetite, which when Ankrd26 is mutated, leads to hyperphagia and diabetes in an obesity-dependent manner.


Assuntos
Tecido Adiposo Branco/metabolismo , Proteínas de Ligação a DNA/fisiologia , Diabetes Mellitus Tipo 2/etiologia , Insulina/metabolismo , Obesidade/fisiopatologia , Receptor de Insulina/metabolismo , Transdução de Sinais , Fatores de Transcrição/fisiologia , Animais , Regulação do Apetite , Restrição Calórica , Proteínas de Ligação a DNA/genética , Diabetes Mellitus Tipo 2/metabolismo , Diabetes Mellitus Tipo 2/prevenção & controle , Modelos Animais de Doenças , Intolerância à Glucose/etiologia , Intolerância à Glucose/metabolismo , Intolerância à Glucose/prevenção & controle , Resistência à Insulina , Peptídeos e Proteínas de Sinalização Intercelular , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Mutantes , Proteínas Mutantes/fisiologia , Obesidade/dietoterapia , Obesidade/metabolismo , Obesidade/prevenção & controle , Especificidade de Órgãos , Fosforilação , Processamento de Proteína Pós-Traducional , Distribuição Aleatória , Fatores de Transcrição/genética
4.
J Cell Mol Med ; 15(5): 1200-9, 2011 May.
Artigo em Inglês | MEDLINE | ID: mdl-20477904

RESUMO

The peritoneal mesothelium exhibits a high regenerative ability. Peritoneal regeneration is concomitant with the appearance, in the coelomic cavity, of a free-floating population of cells whose origin and functions are still under discussion. We have isolated and characterized this cell population and we have studied the process of mesothelial regeneration through flow cytometry and confocal microscopy in a murine model lethally irradiated and reconstituted with GFP-expressing bone marrow cells. In unoperated control mice, most free cells positive for mesothelin, a mesothelial marker, are green fluorescent protein (GFP). However, 24 hrs after peritoneal damage, free mesothelin(+)/GFP(+) cells appear in peritoneal lavages. Cultured lavage peritoneal cells show colocalization of GFP with mesothelial (mesothelin, cytokeratin) and fibroblastic markers. Immunohistochemical staining of the peritoneal wall also revealed colocalization of GFP with mesothelial markers and with procollagen-1 and smooth muscle α-actin. This was observed in the injured area as well as in the surrounding not-injured peritoneal surfaces. These cells, which we herein call peritoneal repairing cells (PRC), are very abundant 1 week after surgery covering both the damaged peritoneal wall and the surrounding uninjured area. However, they become very scarce 1 month later, when the mesothelium has completely healed. We suggest that PRC constitute a type of monocyte-derived cells, closely related with the tissue-repairing cells known as 'fibrocytes' and specifically involved in peritoneal reparation. Thus, our results constitute a synthesis of the different scenarios hitherto proposed about peritoneal regeneration, particularly recruitment of circulating progenitor cells and adhesion of free-floating coelomic cells.


Assuntos
Células da Medula Óssea/citologia , Peritônio/fisiologia , Regeneração , Células-Tronco/citologia , Actinas/biossíntese , Animais , Células da Medula Óssea/metabolismo , Células Cultivadas , Colágeno Tipo I/biossíntese , Epitélio/fisiologia , Queratinas/biossíntese , Mesotelina , Camundongos , Monócitos , Lavagem Peritoneal , Peritônio/citologia , Pró-Colágeno/biossíntese , Coloração e Rotulagem , Células-Tronco/metabolismo
5.
Indian J Physiol Pharmacol ; 53(1): 3-15, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19810571

RESUMO

Relaxation potential of yogic exercises seems to play a vital role in establishing psycho-physical health in reversing the psycho-immunology of emotions under stress based on breath and body awareness. However, mechanism of yogic exercises for restoring health and fitness components operating through psycho-neuro-immunological pathways is unknown. Therefore, a hybrid model of human information processing-psycho-neuroendocrine (HIP-PNE) network has been proposed to reveal the importance of yogic information processing. This study focuses on two major pathways of information processing involving cortical and hypothalamo-pituitary-adrenal axis (HPA) interactions with a deep reach molecular action on cellular, neuro-humoral and immune system in reversing stress mediated diseases. Further, the proposed HIP-PNE model has ample of experimental potential for objective evaluation of yogic view of health and fitness.


Assuntos
Córtex Cerebral/fisiologia , Saúde , Neuroimunomodulação/fisiologia , Estresse Psicológico/imunologia , Yoga/psicologia , Córtex Cerebral/imunologia , Cognição/fisiologia , Homeostase , Humanos , Sistema Hipotálamo-Hipofisário/imunologia , Modelos Biológicos , Sistema Hipófise-Suprarrenal/imunologia , Estresse Psicológico/terapia
6.
Int J Yoga ; 1(1): 21-6, 2008 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-21829280

RESUMO

CONTEXT: Reactive oxygen species are known to aggravate disease progression. To counteract their harmful effects, the body produces various antioxidant enzymes, viz, superoxide dismutase, glutathione reductase etc. Literature reviews revealed that exercises help to enhance antioxidant enzyme systems; hence, yogic exercises may be useful to combat various diseases. AIMS: This study aims to record the efficacy of yoga on superoxide dismutase, glycosylated hemoglobin (Hb) and fasting blood glucose levels in diabetics. SETTINGS AND DESIGN: Forty diabetics aged 40-55 years were assigned to experimental (30) and control (10) groups. The experimental subjects underwent a Yoga program comprising of various Asanas (isometric type exercises) and Pranayamas (breathing exercises) along with regular anti-diabetic therapy whereas the control group received anti-diabetic therapy only. MATERIALS AND METHODS: Heparinized blood samples were used to determine erythrocyte superoxide dismutase (SOD) activity and glycosylated Hb levels and fasting blood specimens collected in fluoride Vacutainers were used for assessing blood glucose. STATISTICAL ANALYSIS USED: Data were analyzed by using 2 × 2 × 3 Factorial ANOVA followed by Scheffe's posthoc test. RESULTS: The results revealed that Yogic exercise enhanced the levels of Superoxide dismutase and reduced glycosylated Hb and glucose levels in the experimental group as compared to the control group. CONCLUSION: The findings conclude that Yogic exercises have enhanced the antioxidant defence mechanism in diabetics by reducing oxidative stress.

7.
Nature ; 419(6905): 384-7, 2002 Sep 26.
Artigo em Inglês | MEDLINE | ID: mdl-12352988

RESUMO

The discovery of electrically conducting organic crystals and polymers has widened the range of potential optoelectronic materials, provided these exhibit sufficiently high charge carrier mobilities and are easy to make and process. Organic single crystals have high charge carrier mobilities but are usually impractical, whereas polymers have good processability but low mobilities. Liquid crystals exhibit mobilities approaching those of single crystals and are suitable for applications, but demanding fabrication and processing methods limit their use. Here we show that the self-assembly of fluorinated tapered dendrons can drive the formation of supramolecular liquid crystals with promising optoelectronic properties from a wide range of organic materials. We find that attaching conducting organic donor or acceptor groups to the apex of the dendrons leads to supramolecular nanometre-scale columns that contain in their cores pi-stacks of donors, acceptors or donor-acceptor complexes exhibiting high charge carrier mobilities. When we use functionalized dendrons and amorphous polymers carrying compatible side groups, these co-assemble so that the polymer is incorporated in the centre of the columns through donor-acceptor interactions and exhibits enhanced charge carrier mobilities. We anticipate that this simple and versatile strategy for producing conductive pi-stacks of aromatic groups, surrounded by helical dendrons, will lead to a new class of supramolecular materials suitable for electronic and optoelectronic applications.

8.
Mol Med ; 7(8): 509-16, 2001 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-11591886

RESUMO

BACKGROUND: With the completion of the human draft genome sequence, efforts are now devoted to identifying new genes. We have developed a computer-based strategy that utilizes the EST database to identify new genes that could be targets for the immunotherapy of cancer or could be involved in the multistep process of cancer. MATERIALS AND METHODS: Utilizing our computer-based screening strategy, we identified a cluster of expressed sequence tags (ESTs) that are highly expressed in breast cancer. Northern blot and reverse transcriptase polymerase chain reaction (RT-PCR) analyses demonstrated the tissue specificity of the computer-generated cluster and comparison with the human genome sequence assisted in isolating a full-length cDNA clone. RESULTS: We identified a new gene that is highly expressed in breast cancer. This gene is expressed at moderate levels in normal breast and testis and at very low levels in liver, brain, and placenta. The gene has two major transcripts of 4.5 kb and 4.1 kb. The 4.5-kb transcript is very abundant in breast cancer, and has an open reading frame of 1382 amino acids. The predicted protein sequence of the 4.5-kb transcript reveals that it has high homology with MRP5, a member of multidrug resistant-associated protein family (MRP). There are seven reported members in the MRP family; we designate this gene as MRP8 (ABCC11). The 4.5-kb MRP8 transcript consists of 31 exons and is located in a genomic region of over 80.4 kb on chromosome 16q12.1. The smaller 4.1-kb transcript of MRP8 is found in testis and may initiate within intron 6 of the gene. CONCLUSION: The selective expression of MRP8 (ABCC11), a new member of ATP-binding cassette transporter superfamily could be a molecular target for the treatment of breast cancer.


Assuntos
Transportadores de Cassetes de Ligação de ATP/metabolismo , Neoplasias da Mama/genética , Bases de Dados de Ácidos Nucleicos , Etiquetas de Sequências Expressas , Proteínas Associadas à Resistência a Múltiplos Medicamentos/genética , Proteínas Associadas à Resistência a Múltiplos Medicamentos/metabolismo , Transportadores de Cassetes de Ligação de ATP/química , Transportadores de Cassetes de Ligação de ATP/genética , Sequência de Aminoácidos , Neoplasias da Mama/metabolismo , Linhagem Celular , Éxons/genética , Feminino , Humanos , Íntrons/genética , Masculino , Dados de Sequência Molecular , Proteínas Associadas à Resistência a Múltiplos Medicamentos/química , Família Multigênica , Alinhamento de Sequência , Software , Testículo/fisiologia , Distribuição Tecidual
9.
Mol Cell Biol ; 21(20): 7020-4, 2001 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11564884

RESUMO

The CSE1L gene, the human homologue of the yeast chromosome segregation gene CSE1, is a nuclear transport factor that plays a role in proliferation as well as in apoptosis. CSE1 and CSE1L are essential genes in Saccharomyces cerevisiae and mammalian cells, as shown by conditional yeast mutants and mammalian cell culture experiments with antisense-mediated depletion of CSE1L. To analyze whether CSE1L is also essential in vivo and whether its absence can be compensated for by other genes or mechanisms, we have cloned the murine CSE1L gene (Cse1l) and analyzed its tissue- and development-specific expression: Cse1l was detected at embryonic day 7.0 (E7.0), E11.0, E15.0, and E17.0, and in adults, high expression was observed in proliferating tissues. Subsequently, we inactivated the Cse1l gene in embryonic stem cells to generate heterozygous and homozygous knockout mice. Mice heterozygous for Cse1l appear normal and are fertile. However, no homozygous pups were born after interbreeding of heterozygous mice. In 30 heterozygote interbreeding experiments, 50 Cse1l wild-type mice and 100 heterozygotes were born but no animal with both Cse1l alleles deleted was born. Embryo analyses showed that homozygous mutant embryos were already disorganized and degenerated by E5.5. This implicates with high significance (P < 0.0001, Pearson chi-square test) an embryonically lethal phenotype of homozygous murine CSE1 deficiency and suggests that Cse1l plays a critical role in early embryonic development.


Assuntos
Proteínas de Transporte/biossíntese , Proteínas de Transporte/genética , Proteínas de Transporte/fisiologia , Proteínas Nucleares/biossíntese , Proteínas Nucleares/genética , Proteínas Nucleares/fisiologia , Transporte Ativo do Núcleo Celular , Alelos , Animais , Apoptose , Northern Blotting , Divisão Celular , Núcleo Celular/metabolismo , Proteína de Suscetibilidade a Apoptose Celular , Clonagem Molecular , Cruzamentos Genéticos , Embrião de Mamíferos/metabolismo , Vetores Genéticos , Genótipo , Heterozigoto , Homozigoto , Humanos , Camundongos , Camundongos Knockout , Modelos Genéticos , Fenótipo , Fatores de Tempo , Distribuição Tecidual , Transfecção
10.
Prostate ; 48(4): 231-41, 2001 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-11536302

RESUMO

BACKGROUND: The database of human expressed sequence tags (dbEST) is a potential source for the identification of tissue specific genes. The database contains sequences that originate from cDNA libraries from different tissues cell types and tumors. METHODS: Computer based analysis identified a cluster of sequence homologous ESTs, containing ESTs derived only from human prostate cDNA libraries. The tissue specificity was examined by multiple tissue RNA dot blots and RT-PCR. The new RNA transcript was characterized using northern blot analysis, RACE-PCR, and a ribonuclease protection assay. RESULTS: We have identified a gene differentially expressed in prostate using EST database analysis and experimental studies. We name the gene GDEP for gene differentially expressed in prostate. The major GDEP transcript is about 520 bp long. GDEP RNA was detected in nine prostate tissue samples, four normal and five cancer. Expression in prostate epithelial cells was established by in situ hybridization. Weak expression was detected in the prostate cancer cell line LNCaP. In vitro transcription/translation indicate that the RNA encodes a small 34 amino acid protein. The major transcript consists of two exons with one large intron (> 15 kb). The GDEP gene was mapped to chromosome 4q21.1 by radiation hybrid mapping. CONCLUSIONS: Our data proves that tissue specific genes can be identified by EST database mining. The prostate specificity of GDEP expression indicates that GDEP may be useful in the diagnosis or treatment of prostate cancer. Published 2001 Wiley-Liss, Inc.


Assuntos
Proteínas de Neoplasias , Próstata/fisiologia , Neoplasias da Próstata/genética , Proteínas/genética , Sequência de Aminoácidos , Animais , Sequência de Bases , Northern Blotting , DNA de Neoplasias/química , DNA de Neoplasias/genética , Etiquetas de Sequências Expressas , Regulação Neoplásica da Expressão Gênica/genética , Humanos , Hibridização In Situ , Masculino , Camundongos , Dados de Sequência Molecular , Próstata/química , Próstata/patologia , Neoplasias da Próstata/química , Neoplasias da Próstata/metabolismo , Proteínas/química , RNA Mensageiro/química , RNA Mensageiro/genética , Técnica de Amplificação ao Acaso de DNA Polimórfico , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Análise de Sequência de DNA
11.
Prostate ; 47(2): 125-31, 2001 May 01.
Artigo em Inglês | MEDLINE | ID: mdl-11340635

RESUMO

BACKGROUND: The database of human Expressed Sequence Tags (dbEST) provides a potential source for identification of tissue-specific genes. This database contains sequences that originate from cDNA libraries from particular tumors, organs or cell types. In this report, we have used the EST database to identify PRAC, a novel gene specifically expressed in human Prostate, prostate cancer, Rectum And distal Colon. METHODS: Using a computer based analysis, a cluster of sequence homologous ESTs was identified which contained ESTs derived only from human prostate cDNA libraries. The tissue specificity was examined by multiple tissue RNA dot blots and RT-PCR. The PRAC transcript and protein was identified using Northern blot analysis, RACE-PCR, primer extension, and western blot. RESULTS: PRAC encode a 382 nucleotide RNA found in prostate, rectum, distal colon, and in three prostate cancer cell lines; LNCaP, PC-3 and DU145. This transcript encodes a 6 kDa nuclear protein. The PRAC gene is located on chromosome 17 at position 17q21, about 4 kbp downstream from the homeodomain Hoxb-13 gene. CONCLUSIONS: Our data proves that the EST database can be a useful tool for discovery of prostate-specific genes. The nuclear localization, identification of potential phosphorylation sites, and possible cotranscription with the Hoxb-13 gene suggest that PRAC may have a regulatory role in the nucleus.


Assuntos
Neoplasias do Colo/metabolismo , Proteínas Nucleares/biossíntese , Neoplasias da Próstata/metabolismo , Sequência de Aminoácidos , Anticorpos Antineoplásicos/análise , Anticorpos Antineoplásicos/biossíntese , Sequência de Bases , Northern Blotting , Western Blotting , Cromossomos Humanos Par 17 , Colo/metabolismo , Colo/fisiologia , Neoplasias do Colo/genética , Etiquetas de Sequências Expressas , Humanos , Masculino , Dados de Sequência Molecular , Proteínas Nucleares/genética , Plasmídeos , Próstata/metabolismo , Próstata/fisiologia , Neoplasias da Próstata/genética , RNA Mensageiro/biossíntese , RNA Mensageiro/genética , Técnica de Amplificação ao Acaso de DNA Polimórfico , Reto/metabolismo , Reto/fisiologia , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Células Tumorais Cultivadas
12.
J Org Chem ; 66(6): 2104-17, 2001 Mar 23.
Artigo em Inglês | MEDLINE | ID: mdl-11300908

RESUMO

The synthesis of functional aromatic bis(sulfonyl chlorides) containing an acetophenone and two sulfonyl chloride groups, i.e., 3,5-bis[4-(chlorosulfonyl)phenyl]-1-acetophenone (16), 3,5-bis(chlorosulfonyl)-1-acetophenone (17), and 3,5-bis(4-(chlorosulfonyl)phenyloxy)-1-acetophenone (18) via a sequence of reactions, involving in the last step the quantitative oxidative chlorination of S-(aryl)- N,N'-diethylthiocarbamate, alkyl- or benzyl thiophenyl groups as masked nonreactive precursors to sulfonyl chlorides is described. A related sequence of reactions was used for the synthesis of the aromatic trisulfonyl chloride 1,1,1-tris(4-chlorosulfonylphenyl)ethane (24). 4-(Chlorosulfonyl)phenoxyacetic acid, 2,2-bis[[[4-(chlorosulfonyl)phenoxyacetyl]oxy]methyl]-1,3-propanediyl ester (27), 5,11,17,23-tetrakis(chlorosulfonyl)-25,26,27,28-tetrakis(ethoxycarbonylmethoxy)calix[4]arene (38), 5,11,17,23,29,35-hexakis(chlorosulfonyl)-37,38,39,40,41,42-hexakis(ethoxycarbonylmethoxy)calix[6]arene (39), 5,11,17,23,29,35,41,47-octakis(chlorosulfonyl)-49,50,51,52,53,54,55,56-octakis(ethoxycarbonylmethoxy)calix[8]arene (40), 5,11,17,23-tetrakis(tert-butyl)-25,26,27,28-tetrakis(chlorosulfonyl phenoxyacetoxy)calix[4]arene (44), 5,11,17,23,29,35-hexakis(tert-butyl)-37,38,39,40,41,42-hexakis(chlorosulfonylphenoxyacetoxy)calix[6]arene (45), and 5,11,17,23,29,35,41,47-octakis(tert-butyl)-49,40,51,52,53,54,55,56-octakis(chlorosulfonylphenoxyacetoxy)calix[8]arene (46) were synthesized by two different multistep reaction procedures, the last step of both methods consisting of the chlorosulfonation of compounds containing suitable activated aromatic positions. 2,4,6-Tris(chlorosulfonyl)aniline (47) was obtained by the chlorosulfonation of aniline. The conformation of two series of multisulfonyl chlorides i.e., 38, 39, 40 and 44, 45, 46, was investigated by (1)H NMR spectroscopy. The masked nonreactive precursor states of the functional aromatic multisulfonyl chlorides and the aromatic multisulfonyl chlorides reported here represent the main starting building blocks required in a new synthetic strategy elaborated for the preparation of dendritic and other complex organic molecules.

13.
Gene ; 265(1-2): 55-60, 2001 Mar 07.
Artigo em Inglês | MEDLINE | ID: mdl-11255007

RESUMO

We have identified a new gene, that is highly expressed in normal and neoplastic prostate, and is also expressed in cardiac atrium, salivary gland, spleen and selective cells in the CNS. Database analyses of ESTs indicated prostate specificity but experimental results showed the expression in other tissues. The full length transcript is 1800 bp with an open reading frame of 526 aa. The amino-terminal 230 residues of the expressed protein has high homology to a family of lectins, especially to the sugar binding domain of ERGIC-53. We therefore designate the new gene ERGL (ERGIC-53-like). There is a transmembrane domain at amino acid positions 468-482 suggesting that the product of ERGL is a type-I membrane protein. In prostate there are two fully processed transcripts one of which is a splice variant with a deletion in the region of the transmembrane domain of the protein.


Assuntos
Lectinas de Ligação a Manose , Proteínas de Membrana/genética , Neoplasias da Próstata/genética , Sequência de Aminoácidos , Animais , Northern Blotting , Mapeamento Cromossômico , Cromossomos Humanos Par 15/genética , Cricetinae , DNA Complementar/química , DNA Complementar/genética , Etiquetas de Sequências Expressas , Feminino , Regulação da Expressão Gênica , Humanos , Hibridização In Situ , Masculino , Proteínas de Membrana/metabolismo , Dados de Sequência Molecular , Neoplasias da Próstata/patologia , Mapeamento de Híbridos Radioativos , Alinhamento de Sequência , Análise de Sequência de DNA , Homologia de Sequência de Aminoácidos , Distribuição Tecidual
14.
Mol Cancer Ther ; 1(2): 79-84, 2001 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-12467225

RESUMO

We have used protein engineering to generate a stable bivalent fragment variable (Fv) molecule from the antimesothelin antibody SS, in which the VH and VL domains of the Fv are linked to each other by a disulfide bond, and the two Fvs are connected by a flexible 15-amino acid (Gly4-Ser)3 linker. The SS (dsFv)2 molecule is fused to a M(r) 38,000 truncated form of Pseudomonas exotoxin to generate a bivalent, disulfide stabilized, (dsFv)2 immunotoxin. The immunotoxin was expressed in Escherichia coli, refolded in vitro, and purified to approximately 95% purity with a high yield of > 10%. Binding studies demonstrated that the (dsFv)2 molecule has 40 times higher apparent affinity for recombinant mesothelin than a monovalent dsFv molecule. The (dsFv)2 immunotoxin was 4-10-fold more cytotoxic to three mesothelin antigen-positive cell lines than the monovalent dsFv immunotoxin. However, when tested in mice bearing tumor cells expressing mesothelin, the antitumor activity of the bivalent immunotoxin is very similar to the activity of the lower affinity monovalent immunotoxin. Our data indicate that increasing affinity of an antibody fragment does not necessarily lead to higher antitumor activity of an immunotoxin in vivo.


Assuntos
ADP Ribose Transferases/farmacologia , Toxinas Bacterianas/farmacologia , Dissulfetos/química , Exotoxinas/farmacologia , Imunotoxinas/farmacologia , Mesotelioma/imunologia , Neoplasias Ovarianas/imunologia , Fatores de Virulência/farmacologia , ADP Ribose Transferases/genética , ADP Ribose Transferases/farmacocinética , Animais , Anticorpos Monoclonais , Antígenos de Neoplasias/metabolismo , Toxinas Bacterianas/genética , Toxinas Bacterianas/farmacocinética , Escherichia coli/genética , Escherichia coli/metabolismo , Exotoxinas/genética , Exotoxinas/farmacocinética , Feminino , Proteínas Ligadas por GPI , Expressão Gênica , Humanos , Fragmentos de Imunoglobulinas/imunologia , Imunotoxinas/genética , Imunotoxinas/farmacocinética , Glicoproteínas de Membrana/metabolismo , Mesotelina , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Nus , Neoplasias Experimentais/tratamento farmacológico , Neoplasias Experimentais/metabolismo , Plasmídeos , Células Tumorais Cultivadas/efeitos dos fármacos , Células Tumorais Cultivadas/metabolismo , Fatores de Virulência/genética , Fatores de Virulência/farmacocinética , Exotoxina A de Pseudomonas aeruginosa
15.
Cancer Res ; 60(17): 4752-5, 2000 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-10987281

RESUMO

Our previous expressed sequence tag database analysis indicates that XAGE-1 is frequently found in Ewing's sarcoma and alveolar rhabdomyosarcoma (U. Brinkmann et al., Cancer Res., 59: 1445-1448, 1999). Using Northern blots and RNA dot blots, we have now found that XAGE-1 is highly expressed in normal testis, in seven of eight Ewing's cell lines, in four of nine Ewing's sarcoma patient samples, and in one of one alveolar rhabdomyosarcoma patient sample. The gene is located on the X chromosome. The full-length cDNA contains 611 bp and predicts a protein of Mr 16,300 with a potential transmembrane domain at the NH2 terminus. XAGE-1 shares homology with GAGE/PAGE proteins in the COOH-terminal end. These findings could be valuable for cancer diagnosis and cancer immunotherapy.


Assuntos
Antígenos de Neoplasias/genética , Sarcoma de Ewing/genética , Sequência de Aminoácidos , Antígenos de Neoplasias/biossíntese , Sequência de Bases , Neoplasias Ósseas/genética , Neoplasias Ósseas/metabolismo , DNA Complementar/genética , DNA Complementar/isolamento & purificação , DNA Complementar/metabolismo , DNA de Neoplasias/genética , DNA de Neoplasias/isolamento & purificação , DNA de Neoplasias/metabolismo , Expressão Gênica , Humanos , Masculino , Osteossarcoma/genética , Osteossarcoma/metabolismo , Fragmentos de Peptídeos/genética , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Rabdomiossarcoma Alveolar/genética , Rabdomiossarcoma Alveolar/metabolismo , Sarcoma de Ewing/metabolismo , Homologia de Sequência de Aminoácidos , Testículo/metabolismo , Testículo/fisiologia , Cromossomo X/genética
16.
Indian J Physiol Pharmacol ; 44(2): 207-10, 2000 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-10846637

RESUMO

On the basis of medical officers diagnosis, thirty three (N = 33) hypertensives, aged 35-65 years, from Govt. General Hospital, Pondicherry, were examined with four variables viz, systolic and diastolic blood pressure, pulse rate and body weight. The subjects were randomly assigned into three groups. The exp. group-I underwent selected yoga practices, exp. group-II received medical treatment by the physician of the said hospital and the control group did not participate in any of the treatment stimuli. Yoga imparted in the morning and in the evening with 1 hr/session. day-1 for a total period of 11-weeks. Medical treatment comprised drug intake every day for the whole experimental period. The result of pre-post test with ANCOVA revealed that both the treatment stimuli (i.e., yoga and drug) were effective in controlling the variables of hypertension.


Assuntos
Hipertensão/terapia , Yoga , Adulto , Idoso , Pressão Sanguínea/fisiologia , Peso Corporal , Feminino , Hemodinâmica/fisiologia , Humanos , Hipertensão/fisiopatologia , Masculino , Pessoa de Meia-Idade , Pulso Arterial
17.
Cancer Lett ; 149(1-2): 105-13, 2000 Feb 28.
Artigo em Inglês | MEDLINE | ID: mdl-10737714

RESUMO

MAT1 is a novel transforming gene which was cloned from a mouse mammary tumor induced by N-methyl-N-nitrosourea in vitro in the presence of lithium as a mitogen. Later, it was found to be identical to the 3' untranslated region (UTR) of the 2.5 kb isoform of PEA-15 (phosphoprotein enriched in astrocytes-15 kDa). We re-cloned MAT1/PEA-15 cDNAs and showed 2.5, 2.0 and 1.8 kb isoforms and confirmed MAT1 localization as reported. The 2.0 and 1.8 kb isoforms were produced by alternative splicing and alternative polyadenylation at the 3' UTR, respectively. To analyze the role of MAT1/PEA-15, we examined the expression of MAT1/PEA-15 mRNA in normal mammary tissues and in mammary tumors. The mammary gland during pregnancy, lactation and weaning showed weak but stable expression. Compared with normal mammary gland, mammary tumors showed stronger expression. Aberrant expression of MAT1/PEA-15 isoforms was found in mouse mammary epithelial cell lines, FSK7 and TM6, which lost the 2.5/2.0 and 2.5 kb isoforms, respectively. In contrast to other oncogenes like c-myc, MAT1/PEA-15 mRNA was extremely stable after actinomycin D and cycloheximide treatments suggesting that other protein expression is prerequisite for degradation of MAT1/PEA-15 mRNA. It evoked the possibility of the 3' UTR of MAT1/PEA-15 (designated as MAT1-T) as a riboregulator in mammary tumorigenesis and necessity for further analysis of human breast cancers as well as mouse mammary tumors.


Assuntos
Glândulas Mamárias Animais/patologia , Glândulas Mamárias Animais/fisiologia , Neoplasias Mamárias Animais/metabolismo , Proteínas de Neoplasias/biossíntese , Fosfoproteínas/biossíntese , Animais , Proteínas Reguladoras de Apoptose , Transformação Celular Neoplásica , Feminino , Humanos , Peptídeos e Proteínas de Sinalização Intracelular , Neoplasias Mamárias Animais/patologia , Camundongos , Gravidez , Isoformas de Proteínas/biossíntese , RNA Mensageiro/biossíntese
18.
Mol Cell Biol ; 20(8): 2902-6, 2000 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-10733593

RESUMO

Mesothelin is a glycosylphosphatidylinositol-linked glycoprotein highly expressed in mesothelial cells, mesotheliomas, and ovarian cancer, but the biological function(s) of the protein is not known. We have analyzed the expression of the mouse mesothelin gene in different developmental stages and in various adult tissues by Northern hybridization. The 2.5-kb mesothelin transcript was detected in the mRNA of E 7.0, E 15.0, and E 17.0 stages of mouse development. In adult tissues the mesothelin gene was expressed in lung, heart, spleen, liver, kidney, and testis. To directly assess the function of the mesothelin in vivo, we generated mutant mice in which the mesothelin gene was inactivated by replacing it with the neomycin resistance gene. In homozygous mutant mice neither mesothelin mRNA nor the protein product was detected. Null mutant mice were obtained in accordance with Mendelian laws, and both males and females produced offspring normally. No anatomical or histological abnormalities were detected in any tissues where mesothelin was reportedly expressed in wild-type mice. Our results demonstrate that mesothelin function is not essential for growth or reproduction in mice.


Assuntos
Desenvolvimento Embrionário e Fetal/genética , Regulação da Expressão Gênica no Desenvolvimento , Glicoproteínas de Membrana/genética , Animais , Proteínas Ligadas por GPI , Deleção de Genes , Mesotelina , Camundongos , RNA Mensageiro/análise , RNA Mensageiro/genética , Reprodução/genética
19.
J Infect Dis ; 181(3): 921-6, 2000 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-10720513

RESUMO

Highly active antiretroviral therapy (HAART), which combines multiple inhibitors of essential human immunodeficiency virus type 1 (HIV-1) enzymes, induces dramatic and sustained viral load reductions in many people infected with HIV-1. However, reservoirs of infected cells capable of producing replication-competent virus persist even after years of HAART, preventing elimination of infection. CD4-PE40 and 3B3(Fv)-PE38, chimeric toxins designed to target the HIV envelope (Env), represent a complementary class of agents that selectively kill productively infected cells. To investigate whether these Env-targeted toxins might serve as adjuncts to HAART for the elimination of infected cells, we tested their ability to augment HAART efficacy in vivo by using a thy/liv SCID-hu mouse model. CD4-PE40 and 3B3(Fv)-PE38 markedly enhanced the capacity of HAART to suppress acute HIV-1 infection and improved HAART-mediated viral load reduction in mice with established HIV-1 infection. These results represent the first demonstration of in vivo anti-HIV-1 efficacy for Env-targeted toxins and support their potential therapeutic utility in combination with HAART.


Assuntos
Fármacos Anti-HIV/uso terapêutico , HIV-1 , Proteínas Recombinantes de Fusão/uso terapêutico , Proteínas do Envelope Viral/antagonistas & inibidores , Animais , Quimioterapia Combinada , Humanos , Fígado/imunologia , Camundongos , Camundongos SCID , Timo/imunologia
20.
Cancer Res ; 59(16): 4018-22, 1999 Aug 15.
Artigo em Inglês | MEDLINE | ID: mdl-10463601

RESUMO

We have generated a stable bivalent Fv molecule [(dsFv)2] of the anti-erbB2 monoclonal antibody e23 in which the V(H) and V(L) domains of the Fv are linked to each other by a disulfide bond and the two Fvs are connected by a 15-amino acid linker (T. K. Bera et al., J. Mol. Biol., 281: 475-483, 1998). The e23 (dsFv)2 molecule is linked to a truncated form of Pseudomonas exotoxin (PE38) to generate a bivalent disulfide-stabilized immunotoxin e23 (dsFv)2-PE38. Compared to the monovalent immunotoxin, the (dsFv)2 immunotoxin showed greatly increased cytotoxicity to four cancer cell lines expressing low levels of erbB2 but not to four other cell lines with high erbB2 expression. e23 (dsFv)2-PE38 was administered i.v. to mice, and its half-life was determined. The t(1/2)alpha and t(1/2)beta were 20 and 325 min, respectively, whereas the corresponding values for the monovalent dsFv immunotoxin were shorter, 6 and 52 min. The antitumor activities of the monovalent and bivalent immunotoxin were compared using mice bearing A431 tumors. Despite the fact that e23 (dsFv)2-PE38 was 13-fold more active than e23 dsFv-PE38 on A431 cells in cell culture, its antitumor activity in mice was <2-fold that of the monovalent immunotoxin. These data show that a large increase in avidity does not always lead to an increase in cytotoxic activity. Furthermore, in one of the cases in which cytotoxic activity in vitro was greatly enhanced, there was only a small increase in antitumor activity.


Assuntos
Exotoxinas/administração & dosagem , Fragmentos Fab das Imunoglobulinas/administração & dosagem , Imunotoxinas/administração & dosagem , Imunotoxinas/farmacocinética , Neoplasias Experimentais/tratamento farmacológico , Receptor ErbB-2/imunologia , Animais , Anticorpos Monoclonais/imunologia , Feminino , Fragmentos Fab das Imunoglobulinas/imunologia , Camundongos , Camundongos Endogâmicos BALB C , Neoplasias Experimentais/imunologia , Sulfetos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA